STANNIOCALCINE 1 POUR LA PRÉVENTION OU LE TRAITEMENT DE LA FIBROSE PULMONAIRE

• 收藏
• 分享

专利权人:

Tohoku University

发明人:

申请号：

EP12812138.1

公开号：

EP2730288B1

申请日:

2012.07.03

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

Provided is a pharmaceutical composition useful as a prophylactic and therapeutic agent for fibrosis, particularly pulmonary fibrosis. One embodiment of the present invention is: a pharmaceutical composition for preventing fibrosis, treating fibrosis and/or preventing the progression of fibrosis, which contains stanniocalcin 1(STC1) as an active ingredient； or a pharmaceutical composition for preventing pulmonary fibrosis, treating pulmonary fibrosis and/or preventing the progression of pulmonary fibrosis, which contains STC1 as an active ingredient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/